Jose Sánchez-Pina

9PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyMedical mycologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 12, 2026
Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC.

|Nov 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Roberto García-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado

|Feb 07, 2025
Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors.

Isabel Rodríguez-Goncer, Jorge Boán, Riansares Carrero-Arribas

|Nov 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena

|Sep 14, 2024
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Maria-Eva Mingot-Castellano, Juan Luis Reguera-Ortega, Denis Zafra Torres

|Dec 18, 2023
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma.

Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente

Pageof 2

Frequent Collaborators

5 joint publications

Joaquín Martínez-López

3 joint publications

Rafael Alonso Fernández

3 joint publications

Maria-Teresa Cedena

2 joint publications

Rosa Ayala